rabeprazole

Sodium rabeprazole, a proton pump inhibitor, is used in peptic ulcers and other acid dyspeptic disorders of upper gastrointestinal tract (2).

* Stomach medications and acid reducers, such as omeprazole (Losec or Prilosec), rabeprazole (Rabecid or Asiphex), dicyclomine (Bentyl), propantheline (ProBanthine), belladonna alkaloids (Donnatal), and hyoscyamine (Levsin)

(2-4) In a randomized controlled trial comparing efficacy and safety of rabeprazole with omeprazole for gastro-esophageal disease, 123 (51%) out of 243 patients completed 5 years of the study; no patients had neoplastic ECL changes.

Eisai, a Japan-based pharmaceutical company, has launched two types of triple formulation combination packs that contain its proton pump inhibitor, Pariet (rabeprazole sodium), in Japan on 14 February, it was reported on Friday.

(Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that it has submitted an application for the proton pump inhibitor Pariet (rabeprazole sodium, "rabeprazole") in Japan seeking a further indication expansion for use in the prevention of recurrent gastric or duodenal ulcer caused by low-dose aspirin therapy and the approval of a new 5 mg tablet formulation.

Ninety patients were randomly and double-blindly divided into Group A (n = 30, rabeprazole 20 mg b.i.d.

In older patients, daily pantoprazole (40 mg) and rabeprazole (20 mg) have been shown to provide better symptom control and healing of esophagitis compared with over-the-counter omeprazole (20 mg) at 8 weeks.

The proton pump inhibitor rabeprazole had a small but significant effect in reducing laryngopharyngeal reflux symptoms after 12 weeks of treatment, Dr.

Prescription PPIs include esomeprazole (Nexium), dexlansoprazole (Dexilant), omeprazole (Prilosec, Zegerid), lansoprazole (Prevacid), pantoprazole (Protonix), and rabeprazole (Aciphex).

If the same holds true with the PPIs, some patients may end up paying more out of pocket, not only for omeprazole, but also for esomeprazole (Nexium), lansoprazole (Prevacid), rabeprazole (AcipHex), and pantoprazole (Protonix).

A cohort study of 113 women found no associated anomalies (relative risk=1.94; 95% confidence interval, 0.36-10.36).[11] Pantoprazole, lansoprazole and rabeprazole are category B medications.